All
Imaging features that predict a treatment response in retinal vascular diseases
January 17th 2024Varun Chaudhary, MD, FRCSC, addressed the big questions in treating patients with retinal vascular diseases: who will and will not respond to treatment and what clues are predictive on imaging, at the Retina 2024 meeting in Maui.
Jane C. Edmond, MD, starts term as 2024 president of AAO
January 15th 2024According to an American Academy of Ophthalmology news release, Edmond’s priorities during her term include addressing physician and staff shortages and protecting patient safety at a time when nonphysicians are trying to expand their scope of practice into eye surgery.
Gentex announces eSight acquisition; will showcase vision technology at CES 2024
January 10th 2024eSight’s medical equipment enhances vision for individuals with over 20 distinct ocular disorders, frequently enabling users to attain 20/20 vision. The Consumer Electronics Show runs January 9-12 in Las Vegas.
Acetylcholinesterase inhibitors associated with lower risk of AMD in Alzheimer disease patients
January 10th 2024The data indicated that patients with Alzheimer’s disease who were treated with acetylcholinesterase inhibitors had a slightly lower hazard of developing AMD compared with untreated patients.